Patents-Review.com
🔗 Permalink
Inventor profile of:

Shane OLWILL

City:

Freising

Country:

Germany

Published Applications:

20

Last publication date:

2024-05-23

Top Assignees for applications by Shane OLWILL

The entities that hold a legal rights for patent applications filed by inventor OLWILL Shane:

Recent patent applications by OLWILL Shane

Shane OLWILL from Freising, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-23
US20240166763A1
Chemistry; metallurgy

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

 #2 | 2022-05-19
US20220153864A1
Chemistry; metallurgy

Novel Fusion Proteins Specific for CD137 and GPC3

 #3 | 2022-05-12
US20220144901A1
Chemistry; metallurgy

Proteins specific for CD137

 #4 | 2022-03-31
US20220098253A1
Chemistry; metallurgy

Lipocalin muteins with binding affinity for LAG-3

 #5 | 2021-12-30
US20210403516A1
Chemistry; metallurgy

Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)

 #6 | 2021-11-25
US20210363257A1
Chemistry; metallurgy

NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1

 #7 | 2021-08-12
US20210246219A1
Chemistry; metallurgy

COMBINATION THERAPIES COMPRISING CD137/HER2 BISPECIFIC AGENTS AND PD-1 AXIS INHIBITORS AND USES THEREOF

 #8 | 2021-07-01
US20210198380A1
Chemistry; metallurgy

ANTI-CANCER FUSION POLYPEPTIDE

 #9 | 2020-05-14
US20200148733A1
Chemistry; metallurgy

NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

 #10 | 2020-05-07
US20200140501A1
Chemistry; metallurgy

Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)

 #11 | 2020-02-13
US20200048317A1
Chemistry; metallurgy

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

 #12 | 2019-11-14
US20190345207A1
Chemistry; metallurgy

Lipocalin muteins with binding affinity for LAG-3

 #13 | 2019-01-31
US20190031729A1
Chemistry; metallurgy

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

 #14 | 2019-01-10
US20190010248A1
Chemistry; metallurgy

Anti-cancer fusion polypeptide

 #15 | 2019-01-10
US20190010231A1
Chemistry; metallurgy

NOVEL FUSION POLYPEPTIDE SPECIFIC FOR LAG-3 AND PD-1

 #16 | 2018-11-22
US20180334499A1
Chemistry; metallurgy

Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)

 #17 | 2018-05-31
US20180148485A1
Chemistry; metallurgy

Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides

 #18 | 2018-05-31
US20180148484A1
Chemistry; metallurgy

Proteins specific for CD137

 #19 | 2018-01-18
US20180016312A1
Chemistry; metallurgy

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

 #20 | 2015-12-03
US20150344538A1
Chemistry; metallurgy

Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
InventorID:

1375253 ⎘